Drug Patents owned by Bionpharma Inc
1. List of Naproxen Sodium drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10028925 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(3 years from now) | |
| US10022344 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(3 years from now) | |
| US11090280 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(3 years from now) | |
| US9693979 | BIONPHARMA INC | Liquid dosage forms of sodium naproxen |
Mar, 2026
(3 years from now) | |
| US9693978 | BIONPHARMA INC | Solvent system for enhancing the solubility of pharmaceutical agents |
Mar, 2026
(3 years from now) | |
Drugs and Companies using NAPROXEN SODIUM ingredient
Market Authorisation Date: 17 February, 2006
Treatment: Temporary relief of minor aches and pains; Temporary reduction of fever
Dosage: CAPSULE;ORAL
How can I launch a generic of NAPROXEN SODIUM before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic